Epicardial vs. transvenous implantable cardioverter defibrillators in children

被引:3
|
作者
Le Bos, Pierre Antoine [1 ]
Pontailler, Margaux [2 ]
Maltret, Alice [1 ]
Kraiche, Diala [1 ]
Gaudin, Regis [2 ]
Barbanti, Claudio [3 ]
Marijon, Eloi [4 ]
Raisky, Olivier [2 ,4 ]
Bonnet, Damien [1 ,4 ]
Waldmann, Victor [1 ,4 ,5 ,6 ]
机构
[1] Hop Univ Necker Enfants Malad, M3C Necker, 149 Rue Sevres, F-75015 Paris, France
[2] Hop Necker Enfants Malad, Dept Pediat Cardiac Surg, 149 Rue Sevres, F-75015 Paris, France
[3] Hop Necker Enfants Malad, Pediat Cardiac Anesthesia & Cardiopulm Unit, 149 Rue Sevres, F-75015 Paris, France
[4] Univ Paris Cite, Paris Cardiovasc Res Ctr, INSERM, 56 Rue Leblanc, F-75015 Paris, France
[5] Hop Europeen Georges Pompidou, Electrophysiol Unit, 20 Rue Leblanc, F-75015 Paris, France
[6] Hop Europeen Georges Pompidou, Adult Congenital Heart Dis Medicosurg Unit, 20 Rue Leblanc, F-75015 Paris, France
来源
EUROPACE | 2023年 / 25卷 / 03期
关键词
Paediatric; Implantable cardioverter defibrillator; Ventricular arrhythmia; Sudden death; Congenital heart disease; CONGENITAL HEART-DISEASE; ADOLESCENTS; REGISTRY; SYSTEMS;
D O I
10.1093/europace/euad015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The implantable cardioverter defibrillator (ICD) has been increasingly used in children. Both epicardial and transvenous approaches are used, with controversy regarding the best option with no specific recommendations. We aimed to compare outcomes associated with epicardial vs. transvenous ICDs in children. Methods and results Data were analysed from a retrospective study including all patients <18-year-old implanted with an ICD in a tertiary centre from 2003 to 2021. Outcomes were compared between epicardial and transvenous ICDs. A total of 122 children with an ICD (mean age 11.5 +/- 3.8 years, 57.4% males) were enrolled, with 84 (64.1%) epicardial ICDs and 38 (29.0%) transvenous ICDs. Early (<30 days) ICD-related complications were reported in 17 (20.2%) patients with an epicardial ICD vs. 0 (0.0%) with a transvenous ICD (P = 0.002). Over a mean follow-up of 4.8 +/- 4.0 years, 25 (29.8%) patients with an epicardial ICD and 9 (23.7%) patients with a transvenous ICD experienced at least one late ICD-related complication [hazard ratio (HR) 1.8, 95% confidence interval (CI) 0.8-4.0]. Implantable cardioverter defibrillator lead dysfunction occurred in 19 (22.6%) patients with an epicardial ICD vs. 3 (7.9%) with a transvenous ICD (HR 5.7, 95% CI 1.3-24.5) and was associated with a higher incidence of ICD-related reintervention (HR 3.0, 95% CI 1.3-7.0). After considering potential confounders, especially age and weight at implantation, this association was no longer significant (P = 0.112). The freedom from ICD lead dysfunction was greater in patients with pleural coils than in those with epicardial coils (HR 0.38, 95% CI 0.15-0.96). Conclusion In children, after a consideration of patient characteristics at implantation, the burden of complications and ICD lead dysfunction appears to be similar in patients with epicardial and transvenous devices. Pleural coils seem to be associated with better outcomes than epicardial coils in this population.
引用
收藏
页码:961 / 968
页数:8
相关论文
共 50 条
  • [1] FAILURES OF EPICARDIAL AND TRANSVENOUS LEADS FOR IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    MATTKE, S
    MULLER, D
    MARKEWITZ, A
    KAULBACH, H
    SCHMOCKEL, M
    DORWARTH, U
    HOFFMANN, E
    STEINBECK, G
    [J]. AMERICAN HEART JOURNAL, 1995, 130 (05) : 1040 - 1044
  • [2] Quality of Life: Comparison of Transvenous vs. Subcutaneous Implantable Cardioverter-Defibrillators.
    Nag, Tonusri
    Shah, Tina
    Shulman, Eric H.
    Henriques, Matthew
    Fattouh, Michael
    Kargoli, Faraj
    Fisher, John D.
    Krumerman, Andrew K.
    Ferrick, Kevin J.
    Jacobson, Jacon J.
    Iwai, Sei
    Ferrick, Aileen
    [J]. CIRCULATION, 2018, 138
  • [3] IMPLANTABLE TRANSVENOUS CARDIOVERTER-DEFIBRILLATORS
    BARDY, GH
    HOFER, B
    JOHNSON, G
    KUDENCHUK, PJ
    POOLE, JE
    DOLACK, GL
    GLEVA, M
    MITCHELL, R
    KELSO, D
    [J]. CIRCULATION, 1993, 87 (04) : 1152 - 1168
  • [4] Subxiphoid Approach to Epicardial Implantation of Implantable Cardioverter Defibrillators in Children
    Haydin, Sertac
    Saygi, Murat
    Ergul, Yakup
    Ozyilmaz, Isa
    Ozturk, Erkut
    Akdeniz, Celal
    Tuzcu, Volkan
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2013, 36 (08): : 926 - 930
  • [5] Clinical Experience of Subcutaneous and Transvenous Implantable Cardioverter Defibrillators in Children and Teenagers
    Pettit, Stephen J.
    Mclean, Andrew
    Colquhoun, Ian
    Connelly, Derek
    McLeod, Karen
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2013, 36 (12): : 1532 - 1535
  • [6] SUBCUTANEOUS VERSUS TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN CHILDREN AND YOUNG ADULTS: A METANALYSIS
    Vetta, Giampaolo
    Parlavecchio, Antonio
    Magnocavallo, Michele
    Valente, Debora
    Caminiti, Rodolfo
    Polselli, Marco
    Vetta, Francesco
    Cirone, Donatello
    Cauti, Fillippo Maria
    Crea, Pasquale
    Rossi, Pietro
    Chierchia, Gian Battista
    Bianchi, Stefano
    De Asmundis, Carlo
    Natale, Andrea
    Della Rocca, Domenico Giovanni
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [7] Unipolar pacing in patients with transvenous implantable cardioverter defibrillators
    Ehrlich, SS
    Shandling, A
    Luckett, CR
    Tobias, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 434A - 435A
  • [8] Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillators: A Brief Review of the Current Landscape
    Zheng, Henry C.
    Afshar, Hamid
    [J]. TEXAS HEART INSTITUTE JOURNAL, 2023, 50 (06)
  • [9] Estimation of the scope of transvenous lead systems in implantable cardioverter defibrillators
    Requena-Carrion, Jesus
    Vaeisaenen, Juho
    Alonso-Atienza, Felipe
    [J]. 2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-16, 2007, : 2595 - 2598
  • [10] Transvenous lead performance of implantable cardioverter-defibrillators and pacemakers
    Mori, Hitoshi
    Kato, Ritsushi
    Ikeda, Yoshifumi
    Tsutsui, Kenta
    Hoya, Hiroki
    Tanaka, Sayaka
    Iwanaga, Shiro
    Nakano, Shintaro
    Muramatsu, Toshihiro
    Sumitomo, Naokata
    Matsumoto, Kazuo
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (03): : 481 - 489